Merck Strikes $2 Billion Deal with Hansoh Pharma for Oral Weight-Loss Drug
Merck (MRK.N) has entered a licensing agreement worth up to $2 billion with Chinese biotech firm Hansoh Pharma (3692.HK) for the development of an experimental oral...
Etiket: AstraZeneca
FDA Approves AstraZeneca’s Imfinzi for Limited-Stage Small Cell Lung Cancer
The U.S. Food and Drug Administration (FDA) has approved AstraZeneca’s immunotherapy drug Imfinzi (durvalumab) for treating certain adults with limited-stage small cell lung cancer (SCLC). The...